# University of Manchester

Organization · id `cardio:org-university-of-manchester` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 027m9bs27](<https://ror.org/027m9bs27>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 027m9bs27 by an exact name.

## The registry's words

- Sponsor name: University of Manchester
- Sponsor class: OTHER
- ROR name: University of Manchester

## Connected pages

- Sponsors: The Efficacy and Safety of Pirfenidone in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction (`cardio:ct-nct02932566`)
- Sponsors: Compression Hosiery to Avoid Post-Thrombotic Syndrome (`cardio:ct-nct04103112`)
- Sponsors: The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy (`cardio:ct-nct04706429`)

## Provenance

Content hash: 2a22a7e35b7d820e65db37b30ec2c7e9bbcfc9d7ae0cc0c58c5638539c745730
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
